Clinical trial
Observational Investigation to Determine Clinical Impact of Continuous Surveillance Monitoring (SM) on General Care Floors With a Nested Study to Determine the Clinical Utility of IPI (Integrated Pulmonary Index).
NCT03050983 is registered in ClinicalTrials.gov with Medtronic - MITG as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Observational Investigation to Determine Clinical Impact of Continuous Surveillance Monitoring (SM) on General Care Floors With a Nested Study to Determine the Clinical Utility of IPI (Integrated Pulmonary Index).
- Lead sponsor
- Medtronic - MITG
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 15, 2017
- Completion date
- September 10, 2020
- Enrollment
- 440 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
respiratory depression, respiratory insufficiency